Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites

Measles viruses derived from the live-attenuated Edmonton-B vaccine lineage are currently investigated as novel anti-cancer therapeutics. In this context, tumor specificity and oncolytic potency are key determinants of the therapeutic index. Here, we describe a systematic and comprehensive analysis...

詳細記述

保存先:
書誌詳細
出版年:Mol Ther Oncolytics
主要な著者: Leber, Mathias Felix, Baertsch, Marc-Andrea, Anker, Sophie Caroline, Henkel, Luisa, Singh, Hans Martin, Bossow, Sascha, Engeland, Christine E., Barkley, Russell, Hoyler, Birgit, Albert, Jessica, Springfeld, Christoph, Jäger, Dirk, von Kalle, Christof, Ungerechts, Guy
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Gene & Cell Therapy 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026446/
https://ncbi.nlm.nih.gov/pubmed/29988512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2018.04.002
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料